Moderna (Brazil) Today
| M1RN34 Stock | BRL 11.06 0.16 1.47% |
Performance0 of 100
| Odds Of DistressLess than 9
|
Moderna is trading at 11.06 as of the 22nd of November 2024, a 1.47 percent increase since the beginning of the trading day. The stock's open price was 10.9. Moderna has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Moderna are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 3rd of December 2022 and ending today, the 22nd of November 2024. Click here to learn more.
Moderna, Inc., a biotechnology company, develops therapeutics and vaccines based on messenger RNA for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts. The company has 7.68 B outstanding shares. More on Moderna
Moving together with Moderna Stock
Moving against Moderna Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Moderna Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Moderna's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Moderna or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
Moderna (M1RN34) is traded on Sao Paulo Exchange in Brazil and employs 3,700 people. The company currently falls under 'Mega-Cap' category with a current market capitalization of 349.58 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Moderna's market, we take the total number of its shares issued and multiply it by Moderna's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Moderna operates under Healthcare sector and is part of Biotechnology industry. The entity has 7.68 B outstanding shares.
Moderna has accumulated about 7.99 B in cash with 13.62 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 19.8, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Moderna Probability Of Bankruptcy
Moderna Risk Profiles
Although Moderna's alpha and beta are two of the key measurements used to evaluate Moderna's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.7 | |||
| Standard Deviation | 3.57 | |||
| Variance | 12.75 | |||
| Risk Adjusted Performance | (0.23) |
Moderna Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Moderna without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Pair Correlation Now
Pair CorrelationCompare performance and examine fundamental relationship between any two equity instruments |
| All Next | Launch Module |
Moderna Corporate Management
Elected by the shareholders, the Moderna's board of directors comprises two types of representatives: Moderna inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Moderna. The board's role is to monitor Moderna's management team and ensure that shareholders' interests are well served. Moderna's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Moderna's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Shannon Klinger | Chief Sec | Profile | |
| James Mock | Chief Officer | Profile | |
| Stephane Bancel | CEO Director | Profile | |
| John Reynders | Chief Officer | Profile | |
| Jerh Collins | Chief Officer | Profile | |
| Lavina CFA | VP Relations | Profile | |
| Juan Andres | Pres Expansion | Profile |
Additional Information and Resources on Investing in Moderna Stock
When determining whether Moderna offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Moderna's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Moderna Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Moderna Stock:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Moderna. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For information on how to trade Moderna Stock refer to our How to Trade Moderna Stock guide.You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.